Affiliate Disclosure: This article contains affiliate links. If you buy through one of them we may earn a commission, at no extra cost to you. We only recommend products we genuinely believe in. As an Amazon Associate I earn from qualifying purchases.
Medical Disclaimer: This content is for informational and educational purposes only and is not medical advice. Always consult a qualified healthcare professional before making health decisions or starting any new treatment.
Medical Disclaimer: This content is for informational and educational purposes only and is not medical advice. Always consult a qualified healthcare professional before making health decisions or starting any new treatment.
Ebola headlines tend to trigger a specific kind of dread. The word itself carries weight – haemorrhagic fever, high fatality rates, the 2014 West Africa outbreak that killed over 11,000 people. When the WHO declares a Public Health Emergency of International Concern, people pay attention.
Here’s the reality check: Ebola is not airborne. It’s not circulating in the UK. The risk to the general public here is effectively zero. But it’s a disease worth understanding – because the science is fascinating, the vaccines are a triumph, and the UK has some of the best outbreak readiness in the world.
Quick Answer: The TL;DR
Ebola 2026: sporadic outbreaks in DRC and Uganda. UK risk is very low. Transmission requires direct contact with bodily fluids – NOT airborne. Symptoms: fever → haemorrhagic signs → multi-organ failure (CFR 50-90% untreated). Vaccines: Ervebo (rVSV-ZEBOV) is 97.5% effective in ring vaccination. UK has four HCID (High Consequence Infectious Disease) units ready. Risk to UK public: effectively zero.
What Is Ebola, Really?
Ebola virus disease is caused by viruses in the genus Ebolavirus, family Filoviridae. There are six species, but four cause human disease:
- Zaire ebolavirus (EBOV) – most lethal, causes largest outbreaks
- Sudan ebolavirus (SUDV)
- Bundibugyo ebolavirus (BDBV)
- Taï Forest ebolavirus (TAFV) – single case
- Reston ebolavirus (RESTV) – asymptomatic in humans, pathogenic in primates
- Bombali ebolavirus – found in bats, not yet known to infect humans
The natural reservoir is almost certainly fruit bats. Primates (gorillas, chimpanzees) get infected and amplify outbreaks but die quickly – they’re dead-end hosts like us.
Major outbreaks: 1976 (first recognised, Yambuku, DRC), 2014-2016 West Africa (28,600 cases, 11,300 deaths), 2018-2020 DRC (3,400 cases), 2022 Uganda (Sudan virus), 2025 DRC (ongoing).
2026 Outbreak Status: Where Are We Now?
| Country | Status (Oct 2026) | Virus | Response |
|---|---|---|---|
| DRC (Nord Kivu/Ituri) | Active | Zaire ebolavirus | Ring vaccination active, ~200 cases |
| Uganda | Contained (Sept 2026) | Sudan ebolavirus | 42-day countdown to declaration |
| Global risk (WHO) | LOW | – | Enhanced surveillance |
Check WHO Disease Outbreak News for real-time updates.
How It Spreads (And How It Absolutely Doesn’t)
This is the most important thing to understand: Ebola is NOT airborne. You cannot catch it from breathing the same air, sitting on the same bus, or being in the same room as someone who has it – unless you have direct contact with their bodily fluids.
| Route | Risk | Details |
|---|---|---|
| Direct fluid contact | HIGH | Blood, vomit, diarrhoea, sweat, semen, breast milk, urine |
| Contaminated surfaces | MODERATE | Bedding, needles, medical equipment, clothing |
| Burial rituals | HIGH | Washing/touching deceased (major driver in 2014-16) |
| Airborne | NONE | No evidence of respiratory transmission |
| Casual contact | NONE | Conversation, shared space, touching intact skin |
| Food/water | NONE | Not foodborne or waterborne |
| Insect vectors | NONE | Not vector-borne |
Critical fact: You are only infectious when symptomatic. During the 2-21 day incubation period, you cannot transmit the virus. This is why contact tracing works – you only need to trace contacts from symptom onset.
Symptoms & Disease Progression
| Phase | Timeline | Symptoms |
|---|---|---|
| Incubation | 2-21 days (avg 8-10) | Asymptomatic, NOT infectious |
| Early (“dry”) | Days 1-3 | Fever, fatigue, muscle pain, headache, sore throat |
| Late (“wet”) | Days 4-7 | Vomiting, diarrhoea, rash, bleeding (gums, eyes, stool), hiccups |
| Critical | Days 7-14 | Shock, multi-organ failure, DIC, death (CFR 50-90% untreated) |
| Recovery | Weeks-months | Viral clearance; persistence in semen/eyes/CSF for months |
Red flags for UK travellers: Fever + travel to outbreak zone + any symptom → NHS 111 immediately. Don’t walk into A&E or GP – call first.
Diagnosis & Testing (UK 2026)
- Clinical suspicion: Travel to affected area + fever + exposure risk
- Testing: PCR (blood) at UKHSA Porton Down / Rare and Imported Pathogens Laboratory (RIPL)
- Turnaround: 4-6 hours (RIPL), 24h (local lab screening)
- Notification: Notifiable disease → UKHSA + local Health Protection Team immediately
Treatment 2026: We Have Options Now
| Intervention | Status | Efficacy |
|---|---|---|
| Supportive care | Standard | Mortality ↓ 50% with early IV fluids, electrolytes, organ support |
| mAb114 (Ansuvimab) | Licensed (FDA/EMA/UK) | Mortality ↓ 35-50% |
| REGN-EB3 (Inmazeb) | Licensed (FDA/EMA/UK) | Mortality ↓ 35-50% |
| Remdesivir | Off-label/compassionate | Some benefit in early disease |
UK stockpiles: mAb114 and REGN-EB3 held by UKHSA for outbreak response.
Vaccines: A Real Success Story
| Vaccine | Type | Efficacy | Deployment |
|---|---|---|---|
| Ervebo (rVSV-ZEBOV) | Recombinant VSV | 97.5% (ring vaccination) | Ring vaccination + HCW |
| Zabdeno/Mvabea | 2-dose (Ad26 + MVA) | High (immunogenicity) | Preventive (HCW, contacts) |
Ervebo is a single-dose vaccine that works within 10 days. It’s used in “ring vaccination” – vaccinate all contacts of a confirmed case, plus their contacts. This broke the transmission chains in the 2018-20 DRC outbreak.
UK stockpile: Ervebo held by UKHSA for healthcare workers and outbreak response.
UK Risk Assessment (2026)
| Scenario | Risk | Mitigation |
|---|---|---|
| Imported case (traveller) | VERY LOW | Entry screening, HCID pathway, immediate isolation |
| Secondary transmission (UK) | EXTREMELY LOW | HCID isolation, contact tracing, PPE |
| Healthcare worker exposure | LOW | PPE protocols, vaccination offer |
| General public | ZERO | No community transmission mechanism |
UK HCID Units (High Consequence Infectious Disease):
- Royal Free Hospital, London (adult & paediatric)
- Newcastle Royal Victoria Infirmary
- Liverpool University Hospital
- Sheffield Teaching Hospitals
These are negative-pressure isolation units with dedicated air handling, anterooms, and staff trained in high-level PPE donning/doffing. They’ve managed imported cases (Lassa fever, Crimean-Congo haemorrhagic fever, MERS) without secondary transmission.
Travel Advice 2026
| Destination | Advice |
|---|---|
| DRC (Nord Kivu/Ituri) | Avoid non-essential travel; enhanced precautions if essential |
| Uganda | Standard precautions; avoid outbreak districts |
| Other affected areas | Check WHO/UKHSA pre-travel |
| Return to UK | Monitor 21 days; fever → 111 immediately |
Infection Control: What HCID Teams Do
- Negative pressure isolation (12+ air changes/hour)
- PPE: EN 14683 Type IIR surgical mask + FFP3 respirator, double gloves, fluid-repellent gown, face shield/visor
- Donning/doffing buddy: Trained observer watches every step
- Waste: Category A infectious waste, autoclave/incineration
- Lab samples: Triple packaging, Category A transport to RIPL
FAQ: The Questions People Ask
Is there Ebola in the UK right now?
No community cases. Occasional imported cases (typically 0-1/year) managed in HCID units with zero secondary transmission.
Can Ebola spread through air?
No. Only direct contact with infected bodily fluids. No respiratory transmission documented in 50 years of outbreaks.
Is there an Ebola vaccine?
Yes. Ervebo (rVSV-ZEBOV) – 97.5% effective in ring vaccination. Used in outbreaks, offered to HCWs and contacts.
Can you survive Ebola?
Yes. With early supportive care + antivirals (mAb114, REGN-EB3), survival >50%. Untreated CFR 50-90%.
How long is Ebola contagious?
Only when symptomatic. Survivors: virus persists in semen up to 12+ months, aqueous humour (eyes), CSF. Use condoms 12 months post-recovery.
Can you get Ebola from food?
No. Not foodborne. Cooking destroys the virus anyway.
What kills Ebola virus?
Bleach (0.5%), alcohol (70%), heat (60°C for 30 min), UV light, standard hospital disinfectants.
Is Ebola in the UK now?
Check UKHSA. Typically 0-1 imported cases/year, managed in HCID units with zero onward spread.
How long does Ebola last?
Acute phase 2-3 weeks. Recovery months. Viral persistence in immune-privileged sites (testes, eyes, CNS) for months to years.
Can Ebola come back after recovery?
Rare relapse (CNS/eyes) – not reinfection. Immune privilege sites can harbour virus.
What’s the death rate?
50-90% untreated. 30-50% with modern supportive care + antivirals. Early presentation is everything.
UK Public Health Response (If Case Detected)
- Isolate in HCID unit immediately
- Confirm at UKHSA Porton Down (RIPL)
- Contact trace – high/low risk categorisation, 21-day monitoring
- Vaccinate contacts (ring vaccination with Ervebo)
- Communicate transparently via UKHSA/NHS
The Bottom Line
Ebola is rare, not airborne, and controllable. The UK has world-class HCID capacity, effective vaccines, and antivirals. Risk to the public is negligible. The 2014-16 West Africa outbreak taught the world hard lessons – and the global response infrastructure is vastly better now.
Stay informed via UKHSA and WHO Disease Outbreak News. Don’t panic. The system works.
Sources
- WHO, UKHSA, CDC, NHS HCID Network
- NEJM, Lancet, Nature Medicine – Ebola vaccine/treatment trials 2022-2026
- WHO Disease Outbreak News, Ebola vaccine trial data 2024-2026
